Lung Cancer
News and reporting on lung cancer.
AstraZeneca Advancing Plan to Launch Biomarker-Driven Drugs as Alternative to Chemo in Breast Cancer
Premium
The drugmaker wants to establish Enhertu in HER2-ultralow breast cancer and even HER2-negative tumors but remains committed to precision medicine strategies.
Burning Rock, Dizal Get Chinese Approval for Lung Cancer CDx
The test, approved by Chinese regulators in early 2022, is designed for the detection of multiple mutation statuses for nine genes.
BioAffinity Technologies' Lung Cancer Test Added to Federal Supply Schedule
The laboratory-developed test analyzes self-collected sputum samples treated with a fluorescent compound.
Pierre Fabre, Scorpion Therapeutics Begin Phase I/II Trial in 'Double-Mutant' NSCLC Patients
The partners are studying a drug designed to target EGFR exon 19 or exon 21 mutations with a co-occurring C797S mutation.
Avistone Biotechnology to Launch Phase I Trial of c-MET Inhibitor in Canada
Canadian health authorities cleared the firm's application to study ANS01 as treatment for advanced solid tumor patients harboring various MET alterations.
Sep 27, 2024
Sep 9, 2024
Jul 26, 2024